SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001144204-19-008588
Filing Date
2019-02-15
Accepted
2019-02-15 11:40:33
Documents
2

Document Format Files

Seq Description Document Type Size
1 SC 13D tv513865_sc13d.htm SC 13D 46785
2 EXHIBIT 7.1 tv513865_ex7-1.htm EX-7.1 22021
  Complete submission text file 0001144204-19-008588.txt   70089
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Subject) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SC 13D | Act: 34 | File No.: 005-90926 | Film No.: 19610400
SIC: 2834 Pharmaceutical Preparations

Mailing Address NO. 35 SECOND GROUP GELIAN VILLAGE LIANGSU TOWN JIANGYAN CITY JIANGSU PROVINCE JIANGYAN F4 225500
Business Address
Zhou Albert Feng (Filed by) CIK: 0001768175 (see all company filings)

Type: SC 13D